203
Participants
Start Date
July 31, 2009
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Aspirin (platelet sensitive versus platelet hyperreactivity)
"The dose of aspirin to be prescribed in this study will be 300 mg orally or by nasogastric tube once a day (assisted therapy), with first dose tomography soon after admission if the patient has no indication of thrombolytic therapy. After the acute phase, patients will receive aspirin at a dose of 200 mg/day. Aspirin will be administered in a simple preparation (no buffer, no extended release)."
University of Sao Paulo, School of Medicine, São Paulo
Collaborators (2)
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
Accumetrics, Inc.
INDUSTRY
Helena Laboratories Point of Care
UNKNOWN
Chrono-Log Corporation
UNKNOWN
University of Sao Paulo
OTHER